Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

NCT00252239 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

112

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment

Conditions

Stroke

Interventions

DRUG: tenecteplase
DRUG: tissue plasminogen activator, tPA

Sponsor

University of Virginia

Collaborators

[object Object]